Literature DB >> 19190955

Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes.

Giovanni Monego1, Vincenzo Arena, Sandra Pasquini, Egidio Stigliano, Roberta Fiaccavento, Ornella Leone, Giorgio Arpesella, Luciano Potena, Franco Oreste Ranelletti, Paolo Di Nardo, Arnaldo Capelli.   

Abstract

The PTHrP/PTH1R signalling system induces calciotropic and myorelaxant effects on the vascular system and plays critical roles in the development of the cardiovascular system. In animal models, PTHrP exerts important effects on heart rate and contractility, particularly under ischemic conditions, while, in human hearts, the expression of PTHrP by cardiomyocytes remains to be defined in both normal and ischemic conditions. The present study has been conducted on 101 autoptical cases and confirmed on nine explanted hearts in order to analyze the expression of the PTHrP/PTH1R system by ventricular myocardium in respect to morphological aspects of the myocardial ischemic damage, myofiber hypertrophy and disarray, coronarosclerosis, age and sex. Immunohistochemistry showed positive cytoplasmic immunostaining for both PTHrP and PTH1R in ventricular cardiomyocytes. The expression levels of the PTHrP/PTH1R system resulted significantly increased (P = 0.0008 and P < 0.0001, respectively) in association with the myocardial ischemic damage and the presence of cardiomyocyte hypertrophy (P = 0.02 and P = 0.009 respectively). Conversely, increased expression levels of PTHrP alone were observed in myofiber disarray (P = 0.04), whereas PTH1R was augmented in coronarosclerosis (P = 0.004) and age (P = 0.001). Taken together, these results demonstrate that human ventricular cardiomyocytes express PTHrP and PTH1R and suggest that the activation of the PTHrP/PTH1R system could represent an aspect of the embryonic gene program typically reactivated by the myocardium when subjected to ischemia and/or hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190955     DOI: 10.1007/s00395-008-0774-4

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  12 in total

1.  A new sense of protection: role of the Ca2+-sensing receptor in ischemic preconditioning.

Authors:  Anna R Busija; Heidi N Fridolfsson; Hemal H Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

2.  Parathyroid hormone is related to QT interval independent of serum calcium in patients with coronary artery disease.

Authors:  Nicholas O Palmeri; Karina W Davidson; William Whang; Ian M Kronish; Donald Edmondson; Marcella D Walker
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-26       Impact factor: 1.468

3.  PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Authors:  Charles Ginsberg; Timothy E Craven; Michel B Chonchol; Alfred K Cheung; Mark J Sarnak; Walter T Ambrosius; Anthony A Killeen; Kalani L Raphael; Udayan Y Bhatt; Jing Chen; Glenn M Chertow; Barry I Freedman; Suzanne Oparil; Vasilios Papademetriou; Barry M Wall; Clinton B Wright; Joachim H Ix; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-13       Impact factor: 8.237

4.  Calcium-sensing receptor: a sensor and mediator of ischemic preconditioning in the heart.

Authors:  Junhui Sun; Elizabeth Murphy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

5.  Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Nisha Bansal; Leila Zelnick; Cassianne Robinson-Cohen; Andy N Hoofnagle; Joachim H Ix; Joao A Lima; Abigail B Shoben; Carmen A Peralta; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  J Am Heart Assoc       Date:  2014-12-02       Impact factor: 5.501

6.  Effect of parathyroid hormone-related protein on intracellular calcium ion and cyclic adenosine monophosphate concentrations in cardiac fibroblasts.

Authors:  Ping Zhou; Qiong Xiao; Zhao-Ting Su; Lin Zhu; Fang-Xia Jin; Xuan-Yi Du
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

7.  Effect of parathyroid hormone on cardiac function in rats with cardiomyopathy.

Authors:  Gang-Yong Wu; Ting Wu; Bai-Da Xu; Yi-Cheng Shi; Zhi-Yuan Cheng; Xiao Zhang; Xiao Wang; Gang-Jun Zong
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

8.  Increased Serum Parathyroid Hormone, Osteocalcin and Alkaline Phosphatase Are Associated with a Long-Term Adverse Cardiovascular Outcome after Coronary Artery Bypass Graft Surgery.

Authors:  Olga Barbarash; Mikhail Zykov; Vasiliy Kashtalap; Oksana Hryachkova; Alexandr Kokov; Olga Gruzdeva; Irina Shibanova; Anton Kutikhin
Journal:  Diagnostics (Basel)       Date:  2019-10-08

Review 9.  Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?

Authors:  Satenik H Adamyan; Knarik R Harutyunyan; Hermine T Abrahamyan; Drastamat N Khudaverdyan; Souren Mkrtchian; Anna S Ter-Markosyan
Journal:  J Investig Med       Date:  2021-05-05       Impact factor: 2.895

10.  Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links.

Authors:  A Fisher; W Srikusalanukul; M Davis; P Smith
Journal:  Clin Interv Aging       Date:  2013-02-25       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.